| 11369595 |
Use of tryptophan metabolites for treating muscle atrophy |
Sophie N. Raynal, Annick Audet, Valerie Autier, Jean-Denis Durand, Micheline Kergoat |
2022-06-28 |
|
| 10350184 |
Derivatives used in the treatment of muscle atrophy |
Sophie N. Raynal, Micheline Kergoat, Valerie Autier, Jean-Denis Durand, Franck Lepifre +1 more |
2019-07-16 |
|
| 9777015 |
Useful thiophene derivatives in the treatment of diabetes |
Franck Lepifre, Gersande R. Lena, Valerie Autier, Micheline Kergoat, Lauren R. Faveriel +2 more |
2017-10-03 |
|
| 9381191 |
Imidazopyridine derivatives useful in treating diabetes |
Franck Lepifre, Gersande R. Lena, Valerie Autier, Micheline Kergoat, Sophie N. Raynal +1 more |
2016-07-05 |
|
| 9365584 |
Thieno [2,3-B] pyridinedione activators of AMPK and therapeutic uses thereof |
Daniel Cravo, Sophie Hallakou-Bozec, Sébastien Bolze, Franck Lepifre, Laurent Faveriel +1 more |
2016-06-14 |
|
| 9284329 |
Thienopyridone derivatives useful as activators of AMPK |
Daniel Cravo, Sophie Hallakou-Bozec, Sébastien Bolze, Franck Lepifre, Laurent Faveriel +1 more |
2016-03-15 |
|
| 9233937 |
Method of stimulating insulin secretion and/or modulating INS-1 kinase with substituted pyrazinones and/or substituted tetrahydroquinoxalinones |
Gerard Botton, Eric Valeur, Micheline Kergoat, Samer Elbawab |
2016-01-12 |
$58,092,000 |
| 9102632 |
Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
Gerard Botton, Micheline Kergoat, Samer Elbawab |
2015-08-11 |
$93,008,000 |
| 8835634 |
Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
Gerard Botton, Eric Valeur, Micheline Kergoat, Samer Elbawab |
2014-09-16 |
$91,413,000 |
| 8815859 |
Substituted pyrazin-2-ones and substituted 5,6,7,8-tetrahydroquinoxalin-2-ones and methods of use thereof |
Gerard Botton, Eric Valeur, Micheline Kergoat, Samer Elbawab |
2014-08-26 |
$59,520,000 |
| 8642617 |
Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
Gerard Botton, Eric Valeur, Micheline Kergoat, Samer Elbawab |
2014-02-04 |
$91,639,000 |
| 8637522 |
Pyrazinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
Gerard Botton, Micheline Kergoat, Samer Elbawab |
2014-01-28 |
$54,750,000 |
| 8609689 |
Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
Gerard Botton, Eric Valeur, Micheline Kergoat, Samer Elbawab |
2013-12-17 |
$54,459,000 |
| 8604202 |
Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators |
Daniel Cravo, Franck Lepifre, Sophie Hallakou-Bozec |
2013-12-10 |
$69,974,000 |
| 8586577 |
Diazepane acetamide derivatives as selective 11B-HSD1 inhibitors |
Denis Carniato, Caroline Leriche, Didier Roche, Liliane Doare |
2013-11-19 |
$50,784,000 |
| 8563729 |
Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators |
Daniel Cravo, Franck Lepifre, Sophie Hallakou-Bozec |
2013-10-22 |
$71,032,000 |
| 8546575 |
NIP thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydroge-nase-1 |
Caroline Leriche, Denis Carniato, Didier Roche, Liliane Doare |
2013-10-01 |
$68,208,000 |
| 8466200 |
2-adamantylurea derivatives as selective 11β-HSD1 inhibitors |
Denis Carniato, Johannes Gleitz, Didier Roche, Bjoern Hock |
2013-06-18 |
$99,229,000 |
| 8431602 |
Beta-amino acid derivatives for treatment of diabetes |
Stefan Bender, Lars Burgdorf, Ulrich Emde, Norbert Beier, Johannes Gleitz |
2013-04-30 |
$96,084,000 |
| 8420642 |
Pyridine derivatives useful as glucokinase activators |
Lars Burgdorf, Norbert Beier, Johannes Gleitz, Daniel Cravo |
2013-04-16 |
$60,818,000 |
| 8415352 |
Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
Gerard Botton, Eric Valeur, Micheline Kergoat, Samer Elbawab |
2013-04-09 |
$69,688,000 |
| 8383838 |
5-oxo-2,3,4,5-tetrahydro-benzo[b]oxepine-4-carboxylic acid amides and 2,3-dihydro-benzo[b]oxepine-4-carboxylic acid amides for treatment and prevention of diabetes typ 1 and 2 |
Christoph Saal, Lars Burgdorf, Ulrich Emde, Norbert Beier, Johannes Gleitz |
2013-02-26 |
$57,688,000 |
| 8329738 |
Use of AMPK-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them |
Gerard Moinet, Dominique Marais, Sophie Hallakou-Bozec |
2012-12-11 |
$46,772,000 |
| 8242107 |
Diazepane-acetamide derivatives as selective 11β-HSD1 inhibitors |
Denis Carniato, Caroline Leriche, Didier Roche, Liliane Doare |
2012-08-14 |
$48,825,000 |
| 8236824 |
N-(pyrazole-3-yl)-benzamide derivatives as glucokinase activators |
Lars Burgdorf, Norbert Beier, Johannes Gleitz, Ulrich Emde, Denis Carniato |
2012-08-07 |
$100,458,000 |
